Leuprotime 22.5 mg Depot Injection 1's Substitute
RXBDR Pharmaceuticals Internationals Pvt Ltd
₹13095
(₹10737.9 per unit)
RXIpca Laboratories Ltd
₹12047.5
(₹12047.5 per unit)
RXZydus Cadila
₹16993
(₹13934.3 per unit)
RXSamarth Life Sciences Pvt Ltd
₹18246.5
(₹14962.1 per unit)
RXHetero Healthcare Ltd
₹17934
(₹17934.0 per unit)
RXEris Life Sciences Ltd
₹18500
(₹18500.0 per unit)
RXBAJAJ HEALTHCARE LTD
₹18990
(₹18990.0 per unit)
RXRanbaxy Laboratories Ltd
₹24892
(₹20411.44 per unit)
Patients may explore substitutes in the following scenarios:
Before you switch from Leuprotime 22.5 mg Depot Injection 1's to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - LEUPRORELIN-22.5MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Leuprotime 22.5 mg Depot Injection 1's is used in the treatment of prostate cancer, breast cancer, endometriosis, and premature puberty. The detailed uses of Leuprotime 22.5 mg Depot Injection 1's are as follows:
Leuprotime 22.5 mg Depot Injection 1's contains Leuprorelin which works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and oestrogen in women. Thereby, Leuprotime 22.5 mg Depot Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of the tumour or causing it to shrink. Also, Leuprotime 22.5 mg Depot Injection 1's is used to treat hormone-responsive breast cancer in pre and postmenopausal women. By reducing testosterone and oestrogen levels, Leuprotime 22.5 mg Depot Injection 1's delays the onset of puberty in children.
The substitutes of Leuprotime 22.5 mg Depot Injection 1's contain the same active salt(s) - LEUPRORELIN-22.5MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Leuprotime 22.5 mg Depot Injection 1's is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Leuprotime 22.5 mg Depot Injection 1's are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Leuprotime 22.5 mg Depot Injection 1's meet the same safety and efficacy standards as Leuprotime 22.5 mg Depot Injection 1's, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Leuprotime 22.5 mg Depot Injection 1's may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Leuprotime 22.5 mg Depot Injection 1's if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Leuprotime 22.5 mg Depot Injection 1's for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Leuprotime 22.5 mg Depot Injection 1's is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Leuprotime 22.5 mg Depot Injection 1's to its substitute. Always consult your doctor before switching.
Leuprotime 22.5 mg Depot Injection 1's contains Leuprorelin, a synthetic hormone that works similar to the natural hormone, gonadotropin-releasing hormone (GnRH) by acting on the pituitary gland and decreases the levels of testosterone in men and oestrogen in women. Thereby, Leuprotime 22.5 mg Depot Injection 1's is used in the treatment of prostate cancer by inhibiting the growth of tumour or causing it to shrink.
Leuprotime 22.5 mg Depot Injection 1's may stop menstrual periods. However, after 7 to 12 weeks of taking the final dose of injection, periods will resume. Please consult a doctor if you have any concerns regarding this.
Leuprotime 22.5 mg Depot Injection 1's should be used with caution in diabetic patients as it may increase the risk of high blood sugar levels. Therefore, it is advised to regularly monitor blood sugar levels while taking Leuprotime 22.5 mg Depot Injection 1's and inform your doctor if you have diabetes before taking Leuprotime 22.5 mg Depot Injection 1's.
Leuprotime 22.5 mg Depot Injection 1's may be used to treat endometriosis (tissue lining the uterus known as endometrium grows outside the uterus). Leuprotime 22.5 mg Depot Injection 1's reduces oestrogen levels and causes menopause temporarily. Thereby, shrink the tissue outside the uterus or stop its growth.
Leuprotime 22.5 mg Depot Injection 1's may decrease bone density, especially when used for the treatment of premature puberty in children. Therefore, regular monitoring of bone density is recommended while taking Leuprotime 22.5 mg Depot Injection 1's.
Leuprotime 22.5 mg Depot Injection 1's should be used with extreme caution in patients suffering from depression as it may worsen the condition. Therefore, inform your doctor if you have any history of depression before taking Leuprotime 22.5 mg Depot Injection 1's.
No, Leuprotime 22.5 mg Depot Injection 1's is not a chemotherapy medicine. It is a synthetic hormone which belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists.
Yes, Leuprotime 22.5 mg Depot Injection 1's is a hormonal medicine that works by altering reproductive hormones. It is not recommended for use during pregnancy as it can harm the fetus and may lead to abortion. If you are pregnant or planning to become pregnant, please inform your doctor.
The common side effects of Leuprotime 22.5 mg Depot Injection 1's are pain, redness, swelling, or skin hardening at the injection site, muscle weakness, bone pain, inability to have an erection, breast tenderness, headache, vaginal dryness, changes in breast size, acne, or mood swings. If any of these side effects persist or worsen, please consult your doctor.
Leuprotime 22.5 mg Depot Injection 1's belongs to the class of synthetic hormones used in the treatment of prostate cancer in men, endometriosis, and hormone-responsive breast cancer in women. Also, it is used to treat premature puberty in children.
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Celon Laboratories Pvt Ltd
Natco Pharma Ltd
Cipla Ltd
Adley Formulations
BDR Pharmaceuticals Internationals Pvt Ltd
Sun Pharmaceutical Industries Ltd
Admac Lifesciences(Oncology)
Halsted Pharma Pvt Ltd
Glenmark Pharmaceuticals Ltd
Neon Laboratories Ltd
United Biotech Pvt Ltd
Alkem Laboratories Ltd
Samarth Life Sciences Pvt Ltd
Zydus Cadila
Zydus Healthcare Ltd
Emcure Pharmaceuticals Ltd
Axiommax Oncology Pvt Ltd
GLS Pharma Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
Hetero Healthcare Pvt Ltd
Fresenius Kabi India Pvt Ltd
Pfizer Ltd
Torrent Pharmaceuticals Ltd
Cadila Healthcare Ltd
Getwell Life Sciences India Pvt Ltd
Therdose Pharma Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Novartis India Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Aureate Healthcare
Biochem Pharmaceutical Industries Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Delarc Pharmaceuticals Pvt Ltd
Zee Laboratories Ltd
Amps Biotech Biotech Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Aimcad Biotech Pvt Ltd
Getwell Oncology Pvt Ltd
Msn Laboratories Pvt Ltd
Reliance Formulation Pvt Ltd
Allieva Pharma Pvt Ltd
Astra Zeneca Pharma India Ltd
Lucien Life Sciences
Getwell Pharmaceutical Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Bhardwaj India Pvt Ltd
Caitlin Oncology
Del Trade International Pvt Ltd
Medaegis Biotek Pvt Ltd
Panacea Biotec Ltd
Cadila Pharmaceuticals Ltd
Dabur India Ltd
Oncostar Pharma Pvt Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cytogen
Symbion Lifescience
Vhb Life Sciences Inc
Zuvius Lifesciences Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Miracalus Pharma Pvt Ltd
Bruck Pharma Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Adley Oncology
Admac Pharma Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Reliance Life Sciences Pvt Ltd
Sayre Therapeutics Pvt Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Zuventus Healthcare Ltd
Astellas Pharma India Pvt Ltd
Boehringer Ingelheim India Pvt Ltd
Mankind Pharma Pvt Ltd
Roche Diagnostics India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley & Bdl
Aprazer Healthcare Pvt Ltd
Aureate Pharma
Caitlin Life Care
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd